Khaled El-Zafarany, attorney for the 16th defendant in the major drug manufacturing case, stated that the prosecution accused his client of participating in a criminal network for drug trafficking. However, the submitted investigations did not prove any direct use by the defendant in distributing drugs.
The defense pointed out that the supplemental investigations by Officer Mohamed Mohsen on April 24, 2025, relied on confidential sources regarding drug manufacturing and distribution activities, but did not specify an exact time for delivery or the defendant’s direct role in the transactions.
It was emphasized that the officers executing the arrest and search on April 26, 2025, were not part of the initial investigations and acted based on unverified information from an anonymous source, raising questions about procedural accuracy.
During the arrest, items including 15 packets resembling synthetic cannabis, cash, two mobile phones, various pieces of gold, and two knives were found in the defendant’s car. However, the defense stressed that these findings do not prove direct involvement in drug distribution, noting that some officers were not documented as having a specific role in the operation.
The defense plea aims to re-evaluate the 16th defendant’s liability in the case, calling for a thorough review of the investigation and arrest procedures.
For more details and latest updates, follow Masr Connect
